中国妊娠期与哺乳期乳腺癌临床实践指南(2022 版)

标题: 中国妊娠期与哺乳期乳腺癌临床实践指南(2022 版)
title: Clinical practice China guidelines for breast cancer during pregnancy and lactation (2022 edition)
版本: 更新版
version: Updated
分类: 标准指南
classification: Standard guideline
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 以中国乳腺疾病专业医生为适用对象。
Guide users: Clinicians specializing in breast diseases in China.
证据分级方法: 本指南证据等级参考GRADE系统,结合中国临床研究特点制定,将证据等级分为Ⅰ、Ⅱ、Ⅲ、Ⅳ4类,量化体现指南编写专家对证据可靠性的评价情况。基于本指南在中国临床实践的可及性,专家组优先选择Ⅰ类和Ⅱ类证据纳入指南评价体系。
Evidence grading method: The level of evidence grading system was developed by referring to the GRADE system combined with findings in clinical studies in China. The levels are classified as Category I, II, III, and IV to quantify the evaluation of the reliability of the evidence by experts on the compiling committees.
制定单位: 中华医学会外科学分会乳腺外科学组
Formulating unit: Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association
注册时间: 2022-10-12
Registration time:
注册编号: PREPARE-2022CN646
Registration number:
指南制订的目的: 为规范妊娠期与哺乳期乳腺癌临床诊治流程,中华医学会外科学分会乳腺外科学组组织国内部分乳腺外科专家在《中华医学会乳腺外科临床实践指南(2021版):妊娠相关乳腺癌临床实践指南》的基础上,参照GRADE(Grading of Recommendations Assess⁃ ment,Development and Evaluation)系统对妊娠期与哺乳期的临床研究证据质量进行评价,并结合我国病人临床特点以及我国乳腺外科临床实践的可及性,对妊娠期与哺乳期乳腺癌临床实践指南部分进行修订,为国内乳腺外科医生临床工作提供参考。
Purpose of the guideline: To standardize the clinical diagnosis and treatment of breast cancer during pregnancy and lactation, based on the Clinical Practice Guidelines for Pregnancy-associated Breast Cancer (PABC): Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021, the Chinese Society of Breast Surgery evaluated the level of evidence in clinical research of breast cancer during pregnancy and lactation by referring to Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Combined with the clinical characteristics of patients and accessibility of the clinical practice of breast surgery in China, the Clinical practice China guidelines for breast cancer during pregnancy and lactation (2022 edition) were created to provide reference for the clinical work of breast surgeons in China.